149 related articles for article (PubMed ID: 9704449)
1. Novel diagnostic and therapeutic strategies with genetically engineered human antibodies.
Ouwehand WH; Watkins N
Vox Sang; 1998; 74 Suppl 2():223-32. PubMed ID: 9704449
[TBL] [Abstract][Full Text] [Related]
2. A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library.
Griffin HM; Ouwehand WH
Blood; 1995 Dec; 86(12):4430-6. PubMed ID: 8541531
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin V region sequences of two human antiplatelet monoclonal autoantibodies derived from B cells of normal origin.
Denomme GA; Mahmoudi M; Cairns E; Bell DA
J Autoimmun; 1994 Aug; 7(4):521-35. PubMed ID: 7980853
[TBL] [Abstract][Full Text] [Related]
4. Recombinant monoclonal antibody technology.
Siegel DL
Transfus Clin Biol; 2002 Jan; 9(1):15-22. PubMed ID: 11889896
[TBL] [Abstract][Full Text] [Related]
5. Engineering mouse monoclonal antibodies for cancer immunotherapy.
Orlandi R
Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
[No Abstract] [Full Text] [Related]
6. Building antibodies from their genes.
Hoogenboom HR; Marks JD; Griffiths AD; Winter G
Immunol Rev; 1992 Dec; 130():41-68. PubMed ID: 1286871
[No Abstract] [Full Text] [Related]
7. Therapeutic antibodies and antibody fusion proteins.
Rohrbach P; Broders O; Toleikis L; Dübel S
Biotechnol Genet Eng Rev; 2003; 20():137-63. PubMed ID: 14997850
[No Abstract] [Full Text] [Related]
8. Production of human antibodies using bacteriophage.
Griffiths AD
Curr Opin Immunol; 1993 Apr; 5(2):263-7. PubMed ID: 8507404
[TBL] [Abstract][Full Text] [Related]
9. The future of monoclonal antibody engineering.
Renner C; Hartmann F; Pfreundschuh M
Ann Hematol; 2001; 80 Suppl 3():B127-9. PubMed ID: 11757694
[No Abstract] [Full Text] [Related]
10. Engineering antibodies for therapy.
Adair JR
Immunol Rev; 1992 Dec; 130():5-40. PubMed ID: 1286872
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy with engineered antibodies.
Russeva MG; Adams GP
Expert Opin Biol Ther; 2004 Feb; 4(2):217-31. PubMed ID: 14998779
[TBL] [Abstract][Full Text] [Related]
12. Development of the primary antibody repertoire.
Alt FW; Blackwell TK; Yancopoulos GD
Science; 1987 Nov; 238(4830):1079-87. PubMed ID: 3317825
[TBL] [Abstract][Full Text] [Related]
13. Evolution of antibody structure during the immune response. The differentiative potential of a single B lymphocyte.
Manser T
J Exp Med; 1989 Oct; 170(4):1211-30. PubMed ID: 2507726
[TBL] [Abstract][Full Text] [Related]
14. The human antibody repertoire: heavy and light chain variable region gene usage in six alloantibodies specific for human HLA class I and class II alloantigens.
Andris JS; Abraham SR; Pascual V; Pistillo MP; Mantero S; Ferrara GB; Capra JD
Mol Immunol; 1995 Oct; 32(14-15):1105-22. PubMed ID: 8544860
[TBL] [Abstract][Full Text] [Related]
15. B-cell superantigens: implications for selection of the human antibody repertoire.
Zouali M
Immunol Today; 1995 Aug; 16(8):399-405. PubMed ID: 7546197
[TBL] [Abstract][Full Text] [Related]
16. Production of antigen-specific human antibodies from mice engineered with human heavy and light chain YACs.
Jakobovits A; Green LL; Hardy MC; Maynard-Currie CE; Tsuda H; Louie DM; Mendez MJ; Abderrahim H; Noguchi M; Smith DH; Zeng Y; David NE; Sasai H; Garza D; Brenner DG; Hales JF; McGuinness RP; Capon DJ; Klapholz S
Ann N Y Acad Sci; 1995 Sep; 764():525-35. PubMed ID: 7486581
[TBL] [Abstract][Full Text] [Related]
17. Immunogenetic analysis of the immune response to pneumococcal polysaccharide.
Baxendale HE; Davis Z; White HN; Spellerberg MB; Stevenson FK; Goldblatt D
Eur J Immunol; 2000 Apr; 30(4):1214-23. PubMed ID: 10760811
[TBL] [Abstract][Full Text] [Related]
18. Generation of diversity in a human anti-viral response.
Rioux JD; Brodeur BR; Larose Y; Ohlin M; Borrebaeck CA; Newkirk MM
Ann N Y Acad Sci; 1995 Sep; 764():381-3. PubMed ID: 7486551
[No Abstract] [Full Text] [Related]
19. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Clarke SC; Ma B; Trinklein ND; Schellenberger U; Osborn MJ; Ouisse LH; Boudreau A; Davison LM; Harris KE; Ugamraj HS; Balasubramani A; Dang KH; Jorgensen B; Ogana HAN; Pham DT; Pratap PP; Sankaran P; Anegon I; van Schooten WC; Brüggemann M; Buelow R; Force Aldred S
Front Immunol; 2018; 9():3037. PubMed ID: 30666250
[TBL] [Abstract][Full Text] [Related]
20. The humoral immune response against blood group antigens at the molecular level.
Ouwehand WH; Bye JM; Gorick BD; Marks JD; Timmers E; Griffin HM; Finnern R; Hughes-Jones N
Vox Sang; 1994; 67 Suppl 3():7-12. PubMed ID: 7975514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
